Develops surface modification technologies for medical devices and in vitro diagnostics.
Surmodics, Inc., headquartered in Eden Prairie, Minnesota, is a leading provider of advanced coating technologies for medical devices and chemical and biological components for diagnostic tests worldwide. The company operates through two key segments: Medical Device and In Vitro Diagnostics (IVD).
The Medical Device segment specializes in surface modification coating technologies that enhance the performance of intravascular medical devices. These coatings improve device access, deliverability, and deployment predictability. Additionally, Surmodics develops drug-delivery coating technologies that enable targeted drug release from medical device surfaces. These innovations cater to diverse markets including coronary, peripheral, neuro-vascular, structural heart, and other medical specialties. The segment also manufactures vascular intervention devices such as drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths.
In the IVD segment, Surmodics focuses on the development, manufacture, and sale of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests. These components, including protein stabilizers, substrates, surface coatings, and antigens, play a crucial role in enhancing the accuracy and reliability of diagnostic tests across clinical and biomedical research settings.
Founded in 1979, Surmodics has built a reeputation for innovation and reliability in the healthcare industry. With a commitment to advancing medical technology and diagnostic capabilities, the company continues to expand its global footprint while maintaining its dedication to delivering high-quality, impactful solutions that improve patient outcomes worldwide.